Becton, Dickinson and Company vs Johnson & Johnson — Stock Comparison
Becton, Dickinson and Company (BDX) and Johnson & Johnson (JNJ) are both listed on US exchanges. This page compares their Q·Score ratings, key fundamentals (P/E, margins, growth), and Wall Street analyst consensus side by side. Data sourced from Yahoo Finance and updated on each page load.
Johnson & Johnson narrowly edges Becton, Dickinson and Company on Q·Score (7.1 vs 6.4 out of 10), led by Quality (9.3 vs 6.4) and Sentiment (6.9 vs 5.1). Becton, Dickinson and Company scores higher on Growth, reflecting stronger revenue and earnings momentum. Analyst consensus targets imply greater upside for BDX (+25.5%) than for JNJ (+10.7%).
Price Performance
Normalised to 100 at period start — shows relative performance.
Q·Score Breakdown
Consensus analyst target of $180.69 is 25% above current price.
⚠ analyst sentiment is cautious.
High-quality business with 26% return on equity and 22% profit margins.
⚠ earnings contracting 53% year-over-year.
Analyst Consensus
Fundamentals
Frequently Asked Questions
BDX vs JNJ: which stock scores better overall?
Based on Q·Score, Johnson & Johnson (JNJ) scores 7.1/10 versus Becton, Dickinson and Company (BDX) at 6.4/10. The Q·Score measures five dimensions: Quality, Health, Growth, Valuation, and Sentiment. For informational purposes only — not financial advice.
Which has better revenue growth: BDX or JNJ?
Becton, Dickinson and Company (BDX) scores higher on Growth (6.2/10 vs 5.1/10). Becton, Dickinson and Company reports revenue growth (5.2% YoY) while Johnson & Johnson reports (9.9% YoY). Growth scores reflect revenue and earnings momentum relative to sector peers.
Is BDX or JNJ more attractively valued?
Becton, Dickinson and Company (BDX) scores higher on Valuation (7.7/10 vs 7.3/10). BDX trades at 10.8× P/E versus JNJ at 18.0×. Valuation is assessed using P/E ratio, analyst price targets, and 52-week range positioning relative to sector peers.
What do analysts say about BDX vs JNJ?
There are 13 analysts covering BDX with a consensus price target of $180.69, and 23 analysts covering JNJ with a consensus target of $252.87. Analyst consensus ratings are aggregated from Wall Street research and do not constitute investment advice.
Which is more profitable: BDX or JNJ?
Johnson & Johnson (JNJ) scores higher on Quality (9.3/10 vs 6.4/10). Net profit margin: BDX at 5.1%, JNJ at 21.8%. Quality scores reflect profit margins, return on equity, and free cash flow generation.
Which has stronger financial health: BDX or JNJ?
Johnson & Johnson (JNJ) scores higher on Financial Health (6.5/10 vs 6.4/10). Market beta: BDX at 0.28, JNJ at 0.26. Health scores consider beta, debt-to-equity, and current ratio. All investments carry risk — this is not investment advice.
What are the market caps of BDX and JNJ?
Becton, Dickinson and Company (BDX) has a market capitalisation of $39.7B, while Johnson & Johnson (JNJ) has a market cap of $549.8B. Market cap data is sourced from Yahoo Finance and reflects the most recent available figures.
Do BDX or JNJ pay dividends?
BDX pays a dividend yield of 2.92%, while JNJ pays a dividend yield of 2.35%. Dividend yields fluctuate with share price and company payout decisions.
Related Comparisons
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →